SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Corcept Reports Positive Phase 2 Bella Trial Results for Lifyorli Combination

CORT

Story updates

12:12:41 PM UTC
SquawkNews
CORCEPT SHARES RISE 3% PREMARKET AFTER POSITIVE RESULTS FROM OVARIAN CANCER DRUG TRIAL
12:19:01 PM UTC
SquawkNews
BUZZ-Corcept股價上漲,因其卵巢癌藥物在中期研究中取得積極結果 10月26日 - ** Corcept Therapeutics(CORT.O)股價在盤前交易中上漲3%,至87.23美元 *
12:19:13 PM UTC
SquawkNews
BUZZ-코셉트, 난소암 치료제 중간 단계 임상시험에서 긍정적인 결과가 나오자 주가 상승 10월26일 - ** 코셉트 테라퓨틱스 CORT.O 의 주가가 장전 거래에서 3% 상승한

Related stories